News

Deal Announcements

Common Sensing Clears Venture Capital Debt

Thursday, September 10, 2015 5:16:00 AM PDT | VentureDeal
   Cambridge, Massachusetts  --  Medical device technology company Common Sensing has received $850,000 in venture capital debt funding, according to an SEC regulatory filing.

Common Sensing has developed a diabetes management product the form of an insulin pen cap that records a person's insulin intake information and transmits it to a connected glucose meter or mobile phone.

Proceeds purposes were not disclosed, nor was how the company intends to use the funding proceeds.

Common Sensing is still seeking $650,000 in additional debt financing, according to the filing.

Company CEO Richard Whalley founded the firm in 2012 and was previously a visiting scientist at the Koch Institute for Integrative Cancer Research, MIT.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1